Trending...
- Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation - 112
- PlanetAI Nature Space (PNS), certificadora Europea, lanza su plataforma EUDR-PNS Ready basada en IA, satélites y trazabilidad blockchain
- Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
VALFIX Medical is developing a trans-catheter solution for patients suffering from valvular heart disease and heart failure.
DOVER, Del. - Michimich -- VALFIX Medical Inc. announces the issuance of a new patent by its Israeli subsidiary VALFIX Medical Ltd. The new Patent US 11,931,021 B2 is titled "Anchors and locks for percutaneous valve implants".
The granted patent outlines multiple locking mechanisms that secure an implant to its target location by applying gripping forces on a surgical suture that passes through the implant.
"It is exciting to receive the new patents as we continue to push the technology forward; our approach to valve repair remains unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. "This patent granted confirms and protects our core technology and adds significant value to our stakeholders."
More on Michimich.com
VALFIX Medical technology is distinguished in its approach to offer valve repair method that truly replicate the surgical annuloplasty approach. Using specially designed anchors and locks VALFIX achieve unparalleled operational flexibility, anatomic precision, and implant stability.
This unique approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
About VALFIX Medical:
VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative transcatheter technology offers a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or
contact us directly at info@valfixmed.com
The granted patent outlines multiple locking mechanisms that secure an implant to its target location by applying gripping forces on a surgical suture that passes through the implant.
"It is exciting to receive the new patents as we continue to push the technology forward; our approach to valve repair remains unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. "This patent granted confirms and protects our core technology and adds significant value to our stakeholders."
More on Michimich.com
- Everwild Music Festival Unveils 2026 Schedule: No Overlapping Sets, Longer Performances, and Epic Late-Night Sets!
- Riggo Production Studio Launches Monthly Content Package for Growing Brands
- Accelerating into Active Oil Production with over 100 Barrels per day now being produced as Dual-revenue engine begins Generating Cash Flow: $IBG
- Finland emerges as clear Eurovision 2026 favourite – analysis of 12 bookmakers by Vedonlyöntisivut
- Mac Mountain Selects netElastic vRouter for LightCraft Broadband-as-a-Service Platform
VALFIX Medical technology is distinguished in its approach to offer valve repair method that truly replicate the surgical annuloplasty approach. Using specially designed anchors and locks VALFIX achieve unparalleled operational flexibility, anatomic precision, and implant stability.
This unique approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
About VALFIX Medical:
VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative transcatheter technology offers a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or
contact us directly at info@valfixmed.com
Source: Valfix medical Inc.
Filed Under: Health
0 Comments
Latest on Michimich.com
- SMAA Highlights the Importance of Strategic Evasion in Karate
- Game Day Private Jets Launches REVUP Platform to Transform Fan & Donor Travel Into a Revenue Engine for College Athletics
- Heritage at South Brunswick Team Celebrates Major Wins at NJBA Sales and Marketing Awards
- InterMountain Announces the Opening of TownePlace Suites Reno
- MAG Magna Corp Targets Trillion-Dollar Opportunity by Tokenizing Rare Earth Assets Critical to AI, EVs, & Defense: MAG Magna Corp.: Stock Symbol: MGNC
- SnapTax Launches AI-Powered Tax Planning Platform for Freelancers and 1099 Workers — Now Free for 90 Days
- Hillside Terrace Highlights How Assisted Living Supports Cognitive Health Before Memory Care
- Congressional Roundtable Exposes Mental Health Crisis: More Spending and Treatment, Worse Results – CCHR Demands Accountability
- Ann Arbor Law Firm Advises Fiduciaries on Estate and Trust Income Tax Obligations
- Michigan Driving Law Updates in 2026 Increase Importance of License Reinstatement Representation
- ArborMotion Offers Comprehensive European Auto Repair Services in Ann Arbor
- Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
- NAIDOC Week Australia 2026 | 50 Years Deadly - Celebrates Culture, Resilience, and Global Connection
- PlanetAI Nature Space (PNS), certificadora Europea, lanza su plataforma EUDR-PNS Ready basada en IA, satélites y trazabilidad blockchain
- Pintsch North America to Exhibit Advanced Rail Signaling Technologies at 2026 ASLRRA Conference
- Compressed Gas Technologies, INC. Highlights the Benefits of On-Site N2 Generation
- Mussio Painting Highlights the Importance of Preparation and Quality Materials
- Bavarian Blast Waterpark Nominated for "Best Indoor Waterpark in the Nation" by USA Today 10Best
- Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
- Instant IP Teams: Bringing Enterprise-Grade Collaboration to IP Protection at the Speed of Thought